Equality, Diversity & Inclusion (EDI)

The ILTS Equality, Diversity & Inclusion (EDI) Committee's key goal is to facilitate educational and professional development and promote an inclusive working environment for all ILTS members.

Mission statement:

The ILTS Equality, Diversity and Inclusion Committee is committed to promoting a supportive environment for all our members, irrespective of race, ethnicity, gender or sexual orientation. Our key goal is to facilitate educational and professional development and promote an inclusive working environment for all ILTS members.


Our committee was originally founded in 2017 as the International Women in Liver Transplantation Committee. It has since evolved into the Equality, Diversity and Inclusion Committee to extend its outreach to an even broader group of ILTS members. We are proud to host the “Women in Liver Transplantation” sessions at our yearly meeting, which have proven to be some of the best-attended sessions.

Key tasks:

Moving forward, we want to strengthen our commitment to equality, diversity, and inclusion through structured mentoring programs open to ILTS members. We will use our resources and network of collaborators to promote academic and professional development. We will continue our advocacy to ensure equal representation of all genders in ILTS committees and among speakers at ILTS meetings. We aim to facilitate research collaborations between centers on topics regarding gender and diversity in liver transplantation.

Key dates:

  1. Develop relevant program content for the ILTS Annual Congress: June-September, submit to program chair (President-Elect) by September 30th.
  2. Review online applications for committee membership annually (January-March) and nominate replacements for members expiring in that year. The process as per ILTS Committees Policy, to be completed four weeks before the Annual Congress.
  3. Meet at Annual Congress (May-July) to review recent activities and member feedback, discuss council input from the most recent Council Meeting and develop an agenda for the following year.
  4. Report twice yearly to ILTS Council: January-February written report for Winter Council Meeting agenda book, May-June written report for Annual Congress Council Meeting agenda book and chair to present in person.

Key performance metrics:

  1. Satisfactory reports to ILTS Council
  2. Participant numbers and feedback re congress events organized by the committee

Committee Members:

  • Claire Francoz, MDPast Chair {2023} Hôpital Beaujon, Clichy, France
  • Sher-Lu Pai, MD Chair {2023} Mayo Clinic Florida, Jacksonville, FL, USA
  • Oya M. Andacoglu Vice Chair 1 {2023} Oklahoma University, OK, USA
  • Dieter Adelmann –  Vice Chair 2 {2024} University of California San Francisco Medical Center, CA, USA
  • Gabriela A. Berlakovich, MD Affiliated Councilor {2023} Medical University of Vienna, Austria
  • Manhal Izzy, MD {2025} Vanderbilt University Medical Center, Nashville, USA
  • Emmanouil Giorgakis {2025} UAMS Medical Center, Arkansas, USA
  • Nyingi Kemmer {2025} Tampa General Hospital – University of South Florida, Florida, USA
  • Victoria Aguilera, PhD {2023} Hospital Universitario La Fe, Valencia, Spain
  • Chiara Becchetti, MD {2025} Hepatology, UVCM, Inselspital, University of Bern, Switzerland
  • Iman Fawzy Montesser {2025} Ain Shams University, Cairo, Egypt
  • Simantika Ghosh {2023} Narayana Health, Kolkata, India
  • Keri Lunsford {2025} Methodist Hospital Houston, Houston, TX, USA
  • Martin Montenovo, MD {2024} Vanderbilt University, Nashville, TN, USA
  • Anna Mrzljak, MD, PhD {2023} University Hospital Merkur, Zagreb, Croatia
  • Irene Scalera {2023} A.O.R.N Cardarelli, Altamura, Italy

*Committee terms end at Annual Congress in year shown in brackets


Committee Members testimonies

Committee Terms of Reference